🇺🇸 FDA
Patent

US 7094405

Peptides which elicit a high neutralizing antibody titer, cytotoxic T lymphocyte response and T helper cell response in a broad range of MHC type recipients

granted A61KA61K2039/545A61K2039/55516

Quick answer

US patent 7094405 (Peptides which elicit a high neutralizing antibody titer, cytotoxic T lymphocyte response and T helper cell response in a broad range of MHC type recipients) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2039/545, A61K2039/55516, A61K2039/55566, A61K2039/55577